Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Join | Sign in
Home>Videos>This Video
  Videos

Return

Old Structures - New Targets for Antivirulence Salicylidene Acylhydrazide Compounds
Select Biosciences Ltd

Salicylidene acylhydrazide compounds have been demonstrated to perturb the function of the type three secretion of many important human pathogens including Escherichia coli O157 and Yersinia pseudotuberculosis. The actual protein targets of these compounds had, to this date, been unknown. In this work we present the identification and verification of three such protein targets. Each protein was identified using a combination of affinity chromatography and Far-western analyses followed by phenotypic testing of defined bacterial mutants using in vitro and in vivo assays. , , The structure of the target protein with the greatest effect on virulence in Yersinia pseudotuberculosis was solved in 3 forms by X-ray crystallography. In combination with studies of inactive mutants, and conformational changes in the protein caused by redox active state, we present localised regions likely to bind to the drug. Work is under way to solve the structure of protein and compound that will permit refinement of the salicylidene acylhydrazides with the long-term goal of developing clinically-useable drugs.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
TSRI Scientists Find Clues to Cancer Drug Failure
A pair of studies show how the primary protein responsible for multidrug chemotherapy resistance changes shape.
Acoustic Tweezers Device Expands the Range of X-ray Crystallography
A microfluidic device that utilizes ultrasound waves produced by piezoelectric transducers.
Study Could Pave the Way for Painkillers with Fewer Side Effects
Research at SLAC explores promising alternative to morphine.
Lighting Up A New Path For Novel Synthetic Polio Vaccine
Crystal structures and electron microscopy images are being used to develop a vaccine to target the polio virus.
Diamonds Could Help Bring Proteins Into Focus
New technique could use tiny diamond defects to reveal unprecedented detail of molecular structures.
New Discoveries In Primary Pathway for Neurological Diseases
Discovery could lead to new drug design for neurodegenerative diseases.
Purdue Research Suggests Approach to Treat Virus Causing Respiratory Illness
Enterovirus D68 has stricken children with serious respiratory infections.
Cambridge Structural Database Reaches 750,000 Entry Milestone
Essential resource to scientists around the world reaches historic record.
Scientists Gain First Glimpse of One of Nature’s Measuring ‘Rulers’
New findings offer potential to outsmart bacterial infections.
Did You Hear The One About The Two Businessmen On A Plane?
EquipNet’s vision ‘to revolutionize the way companies manage their surplus assets’ was first conceived at 30,000 feet somewhere between Chicago and Boston in 1999. Here we learn more about the company's first 15 years.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters